Zhongzhu Medical Holdings Co Ltd (600568) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Zhongzhu Medical Holdings Co Ltd (600568) has a cash flow conversion efficiency ratio of 0.016x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥26.78 Million ≈ $3.92 Million USD) by net assets (CN¥1.71 Billion ≈ $250.64 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See how many days can Zhongzhu Medical Holdings Co Ltd fund operations to measure how many days the company can operate on defensive assets alone.
Zhongzhu Medical Holdings Co Ltd - Cash Flow Conversion Efficiency Trend (1999–2025)
This chart illustrates how Zhongzhu Medical Holdings Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Zhongzhu Medical Holdings Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Zhongzhu Medical Holdings Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Cannae Holdings Inc
NYSE:CNNE
|
-0.018x |
|
Shengtak New Material Co Ltd
SHE:300881
|
-0.093x |
|
Shenzhen Refond Optoelectronics Co Ltd
SHE:300241
|
0.014x |
|
Suprajit Engineering Limited
NSE:SUPRAJIT
|
0.063x |
|
HDC Holdings Co Ltd
KO:012630
|
-0.021x |
|
McCormick & Company Incorporated
NYSE:MKC-V
|
0.007x |
|
GuangDong Rifeng Electric Cable Co Ltd
SHE:002953
|
0.021x |
|
Grendene S.A
SA:GRND3
|
0.002x |
Annual Cash Flow Conversion Efficiency for Zhongzhu Medical Holdings Co Ltd (1999–2025)
The table below shows the annual cash flow conversion efficiency of Zhongzhu Medical Holdings Co Ltd from 1999 to 2025. For the full company profile with market capitalisation and key ratios, see how much is Zhongzhu Medical Holdings Co Ltd worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥1.63 Billion ≈ $238.63 Million |
CN¥56.08 Million ≈ $8.21 Million |
0.034x | +83.70% |
| 2024-12-31 | CN¥1.74 Billion ≈ $255.02 Million |
CN¥32.63 Million ≈ $4.77 Million |
0.019x | +1649.82% |
| 2023-12-31 | CN¥2.59 Billion ≈ $379.07 Million |
CN¥2.77 Million ≈ $405.57K |
0.001x | -87.69% |
| 2022-12-31 | CN¥2.94 Billion ≈ $429.73 Million |
CN¥25.52 Million ≈ $3.74 Million |
0.009x | -65.54% |
| 2021-12-31 | CN¥3.73 Billion ≈ $545.62 Million |
CN¥94.04 Million ≈ $13.76 Million |
0.025x | -59.55% |
| 2020-12-31 | CN¥3.98 Billion ≈ $582.38 Million |
CN¥248.15 Million ≈ $36.31 Million |
0.062x | -60.51% |
| 2019-12-31 | CN¥3.89 Billion ≈ $569.54 Million |
CN¥614.57 Million ≈ $89.93 Million |
0.158x | +351.03% |
| 2018-12-31 | CN¥4.26 Billion ≈ $622.92 Million |
CN¥-267.76 Million ≈ $-39.18 Million |
-0.063x | -7.91% |
| 2017-12-31 | CN¥6.15 Billion ≈ $899.41 Million |
CN¥-358.29 Million ≈ $-52.43 Million |
-0.058x | -218.18% |
| 2016-12-31 | CN¥6.01 Billion ≈ $879.82 Million |
CN¥296.58 Million ≈ $43.40 Million |
0.049x | -30.98% |
| 2015-12-31 | CN¥2.65 Billion ≈ $387.06 Million |
CN¥189.05 Million ≈ $27.66 Million |
0.071x | +1185.81% |
| 2014-12-31 | CN¥2.58 Billion ≈ $377.47 Million |
CN¥14.34 Million ≈ $2.10 Million |
0.006x | +84.24% |
| 2013-12-31 | CN¥1.18 Billion ≈ $172.51 Million |
CN¥3.56 Million ≈ $520.44K |
0.003x | +106.40% |
| 2012-12-31 | CN¥1.03 Billion ≈ $150.39 Million |
CN¥-48.43 Million ≈ $-7.09 Million |
-0.047x | +42.30% |
| 2011-12-31 | CN¥915.88 Million ≈ $134.02 Million |
CN¥-74.80 Million ≈ $-10.94 Million |
-0.082x | +88.58% |
| 2010-12-31 | CN¥742.77 Million ≈ $108.69 Million |
CN¥-531.24 Million ≈ $-77.74 Million |
-0.715x | -91.30% |
| 2009-12-31 | CN¥677.27 Million ≈ $99.11 Million |
CN¥-253.20 Million ≈ $-37.05 Million |
-0.374x | -353.89% |
| 2008-12-31 | CN¥616.24 Million ≈ $90.17 Million |
CN¥90.74 Million ≈ $13.28 Million |
0.147x | +2020.96% |
| 2007-12-31 | CN¥514.98 Million ≈ $75.36 Million |
CN¥3.58 Million ≈ $523.18K |
0.007x | -93.14% |
| 2006-12-31 | CN¥479.24 Million ≈ $70.13 Million |
CN¥48.49 Million ≈ $7.10 Million |
0.101x | -1.27% |
| 2005-12-31 | CN¥558.76 Million ≈ $81.76 Million |
CN¥57.27 Million ≈ $8.38 Million |
0.102x | +1726.33% |
| 2004-12-31 | CN¥489.48 Million ≈ $71.63 Million |
CN¥2.75 Million ≈ $401.95K |
0.006x | +380.94% |
| 2003-12-31 | CN¥472.91 Million ≈ $69.20 Million |
CN¥551.80K ≈ $80.75K |
0.001x | -8.44% |
| 2002-12-31 | CN¥444.66 Million ≈ $65.07 Million |
CN¥566.66K ≈ $82.92K |
0.001x | -87.95% |
| 2001-12-31 | CN¥433.47 Million ≈ $63.43 Million |
CN¥4.59 Million ≈ $671.09K |
0.011x | -69.40% |
| 2000-12-31 | CN¥82.36 Million ≈ $12.05 Million |
CN¥2.85 Million ≈ $416.77K |
0.035x | -64.08% |
| 1999-12-31 | CN¥69.76 Million ≈ $10.21 Million |
CN¥6.72 Million ≈ $982.65K |
0.096x | -- |
About Zhongzhu Medical Holdings Co Ltd
Zhongzhu Healthcare Holding Co.,Ltd engages in the research and development, production, and sale of drugs in China. The company offers ophthalmology drugs, including Pearl eye drops, Sodium Cromolyn eye drops, Acyclovir eye drops, Hydroxybenzone Hydrochloride eye drops, Acyclovir dispersible tablets, and Gatifloxacin tablets; and products related to tumor treatment. It is also involved in produc… Read more